Skip to content
The Policy Vault
Methodology
Why
Contact
Coverage
/
Point32Health
/
Yesintek (ustekinumab-kfce)
/
Psoriatic Arthritis
← Back
Yesintek (ustekinumab-kfce) — Point32Health
Psoriatic Arthritis
Initial criteria
Documented diagnosis of psoriatic arthritis
Patient age ≥ 6 years
Prescribed by or in consultation with a rheumatologist or dermatologist
